| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |